Evaluate F901318 (Olorofim) Treatment of Invasive Fungal Infections in Participants Lacking Treatment Options

NCT03583164 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

203

Enrollment

INDUSTRY

Sponsor class

Conditions

Invasive Fungal Infections

Interventions

DRUG: Olorofim

Sponsor

F2G Biotech GmbH

Collaborators

[object Object]